by GlobeNewsWire | Apr 7, 2016 | Globe Newswire
MADISON, Wis., April 07, 2016 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ:CLRB) (“Cellectar” or the “company”), an oncology-focused biotechnology company, announced today that on April 6, 2016, the NASDAQ Listing Qualifications Panel (the “panel”)...
by GlobeNewsWire | Mar 4, 2016 | Globe Newswire
MADISON, Wis., March 04, 2016 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ:CLRB), an oncology-focused biotechnology company, today announces a 1-for-10 reverse stock split of its common stock, effective at the close of business today. Shares of...
by GlobeNewsWire | Jan 7, 2016 | Globe Newswire, GNW Alerts
MADISON, Wis., Jan. 07, 2016 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ:CLRB), an oncology-focused biotechnology company, announces today its CEO, Jim Caruso, will be presenting at the Biotech Showcase in San Francisco on January 12, 2016 at 5:00 PM...
by GlobeNewsWire | Dec 9, 2015 | Globe Newswire
MADISON, Wis., Dec. 9, 2015 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ:CLRB), an oncology-focused biotechnology company, today announces it plans to provide performance data from the first cohort of patients enrolled in its orphan drug designated...
by GlobeNewsWire | Nov 20, 2015 | Globe Newswire
MADISON, Wis., Nov. 20, 2015 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ:CLRB), an oncology-focused biotechnology company, today announces that its chief scientific officer and company founder, Jamey Weichert, Ph.D., received the Harry Fisher award...